Filing Details

Accession Number:
0001415889-24-012359
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-06 17:26:00
Reporting Period:
2024-05-02
Accepted Time:
2024-05-06 17:26:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651036 Michael Landsittel C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-02 10,000 $36.05 57,286 No 4 M Direct
Common Stock Disposition 2024-05-02 10,000 $105.00 47,286 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-05-02 10,000 $0.00 10,000 $36.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-02-16 No 4 M Direct
Footnotes
  1. Effected through a trading plan adopted on December 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on February 16, 2017 and is fully vested as of the transaction date.